Live Quote · NASDAQCLLSHealthcare· Biotechnology

Cellectis S.A.

$0.92▼ 7.89%($-0.08)
MKT CAP $92.76MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
51/100
▌ Mixed
67
Valuation
55
Profitability
55
Growth
48
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLLS research report →

Analyst Price Target
$2.15+133.5% vs. today

Range $1.3 – $3

Analyst RatingBuy
12 Buy3 Hold2 Sell

Price Chart

-80.73% · this period
$5.35$3.14$0.92Nov 20May 26Nov 20
52-Week Range1% of range
Low
$0.88
Current
$0.92
High
$5.45